Mednax Inc Stock Analysis

Mednax Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.91. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mednax Inc has Price/Earnings To Growth (PEG) ratio of 0.88. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 20th of December 2013. Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. Pediatrix Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 5000 people. To find out more about Mednax Inc contact James MD at 954 384 0175 or learn more at https://www.pediatrix.com.

Mednax Inc Investment Alerts

Mednax Inc Upcoming and Recent Events

Mednax Largest EPS Surprises

View All Earnings Estimates

Mednax Thematic Classifications

Mednax Stock Institutional Investors

Note, although Mednax's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mednax Market Capitalization

The company currently falls under 'Small-Cap' category with a market capitalization of 789.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mednax's market, we take the total number of its shares issued and multiply it by Mednax's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Mednax Profitablity

The company has Net Profit Margin (PM) of (0.03) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.08 %, which signifies that for every $100 of sales, it has a net operating income of $0.08.

Management Efficiency

Mednax Inc has Return on Asset (ROA) of 0.0432 % which means that for every $100 of assets, it generated a profit of $0.0432. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.0694) %, which implies that it produced no returns to current stockholders. Mednax's management efficiency ratios could be used to measure how well Mednax manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.07. In addition to that, Return On Capital Employed is expected to decline to 0. At present, Mednax's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 86.3 M, whereas Total Current Assets are forecasted to decline to about 382.4 M.

Technical Drivers

As of the 25th of April, Mednax secures the Mean Deviation of 1.81, downside deviation of 2.86, and Risk Adjusted Performance of 0.0182. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mednax Inc, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to break down nineteen technical drivers for Mednax, which can be compared to its peers in the industry. Please verify Mednax Inc treynor ratio, and the relationship between the standard deviation and downside variance to decide if Mednax Inc is priced some-what accurately, providing market reflects its recent price of 9.24 per share. Given that Mednax Inc has jensen alpha of (0.12), we recommend you to check Mednax's last-minute market performance to make sure the company can sustain itself at a future point.

Mednax Inc Price Movement Analysis

Mednax Inc Insider Trading Activities

Mednax Outstanding Bonds

Mednax Predictive Daily Indicators

Mednax Corporate Filings

Mednax Forecast Models

Mednax's time-series forecasting models are one of many Mednax's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mednax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mednax prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mednax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mednax. By using and applying Mednax Stock analysis, traders can create a robust methodology for identifying Mednax entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mednax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mednax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Mednax Inc stock analysis indicators help investors evaluate how Mednax stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mednax shares will generate the highest return on investment. By understating and applying Mednax stock analysis, traders can identify Mednax position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Mednax Inc information on this page should be used as a complementary analysis to other Mednax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.

Is Mednax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.